Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuhiro Yoshino

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Frontiers in Pharmacology|November 11, 2024
Machine learning model for predicting the cold-heat pattern in Kampo medicine: a multicenter prospective observational studyAyako Maeda-Minami, Tetsuhiro Yoshino, Kotoe Katayama, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|July 28, 2023
Contribution of traditional Japanese Kampo medicines, kakkonto with shosaikotokakikyosekko, in treating patients with mild-to-moderate coronavirus disease 2019: Further analysis of a multicenter, randomized controlled trialShin Takayama, Takao Namiki, Ryutaro Arita, et al.
Trials|January 7, 2021
A structured summary of a study protocol for a multi-center, randomized controlled trial (RCT) of COVID-19 prevention with Kampo medicines (Integrative Management in Japan for Epidemic Disease by prophylactic study: IMJEDI P1 study)Takao Namiki, Shin Takayama, Ryutaro Arita, et al.
Frontiers in Pharmacology|November 28, 2022
Multicenter, randomized controlled trial of traditional Japanese medicine, kakkonto with shosaikotokakikyosekko, for mild and moderate coronavirus disease patientsShin Takayama, Takao Namiki, Ryutaro Arita, et al.
Internal Medicine (Tokyo, Japan)|November 3, 2022
Conventional and Kampo Medicine Treatment for Mild-to-moderate COVID-19: A Multicenter, Retrospective, Observational Study by the Integrative Management in Japan for Epidemic Disease (IMJEDI Study-observation)Shin Takayama, Tetsuhiro Yoshino, Sayaka Koizumi, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Frontiers in Pharmacology|November 11, 2024
Machine learning model for predicting the cold-heat pattern in Kampo medicine: a multicenter prospective observational studyAyako Maeda-Minami, Tetsuhiro Yoshino, Kotoe Katayama, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|July 28, 2023
Contribution of traditional Japanese Kampo medicines, kakkonto with shosaikotokakikyosekko, in treating patients with mild-to-moderate coronavirus disease 2019: Further analysis of a multicenter, randomized controlled trialShin Takayama, Takao Namiki, Ryutaro Arita, et al.
Trials|January 7, 2021
A structured summary of a study protocol for a multi-center, randomized controlled trial (RCT) of COVID-19 prevention with Kampo medicines (Integrative Management in Japan for Epidemic Disease by prophylactic study: IMJEDI P1 study)Takao Namiki, Shin Takayama, Ryutaro Arita, et al.
Frontiers in Pharmacology|November 28, 2022
Multicenter, randomized controlled trial of traditional Japanese medicine, kakkonto with shosaikotokakikyosekko, for mild and moderate coronavirus disease patientsShin Takayama, Takao Namiki, Ryutaro Arita, et al.
Internal Medicine (Tokyo, Japan)|November 3, 2022
Conventional and Kampo Medicine Treatment for Mild-to-moderate COVID-19: A Multicenter, Retrospective, Observational Study by the Integrative Management in Japan for Epidemic Disease (IMJEDI Study-observation)Shin Takayama, Tetsuhiro Yoshino, Sayaka Koizumi, et al.
Pageof 5